Mein Warenkorb

HLA-A*3303 | B2M

Produktanfrage

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
KLT-1101KLT-1101Phase 2 ClinicalKang Litai Pharmaceutical Co LtdSolid tumours; Leukopenia; Thrombocytopenia; Melanoma; Sarcoma, Kaposi
Details
Edodekin alfaRO 247472; YM 01CPhase 2 ClinicalWistar Institute, Valeant, F. Hoffmann-La Roche LtdBreast Neoplasms; Leishmaniasis; Bacterial Infections; Melanoma; Sarcoma, Kaposi; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Carcinoma, Squamous Cell; Hepatitis C; Asthma; Solid tumours; Hepatitis B; Graft vs Host Disease; Carcinoma, Ovarian Epithelial; Neoplasms; Malaria; Carcinoma, Renal Cell; Abdominal Neoplasms; Squamous Cell Carcinoma of Head and Neck; HIV Infections
Details
GEN-1phIL-12-005/PPC; GEN-1; EGEN-001; IMNN-001Phase 2 ClinicalExpression GeneticsCystadenocarcinoma; Ovarian Neoplasms; Cystadenocarcinoma, Serous; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Endometrioid
Details
RTX-224RTX-224Phase 2 ClinicalRubius Therapeutics IncSkin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Carcinoma, Non-Small-Cell Lung
Details
SON-1010SON-1010Phase 2 ClinicalSonnet Biotherapeutics IncOvarian Neoplasms; Solid tumours
Details
ASP-9801ASP-9801Phase 1 ClinicalAstellas Pharma IncSolid tumours; Neoplasms; Neoplasm Metastasis
Details
ANK-101ANK101; ANK-101Phase 1 ClinicalAnkyra Therapeutics IncSolid tumours; Soft Tissue Injuries; Skin Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
CLN-617CLN-617Phase 1 ClinicalCullinan OncologySolid tumours
Details
KB-707KB-707; KB707Phase 1 ClinicalKrystal Biotech IncSolid tumours; Skin Melanoma; Carcinoma, Basal Cell; Carcinoma, Renal Cell; Small Cell Lung Carcinoma; Neoplasms; Sarcoma; Osteosarcoma; Colorectal Neoplasms; Carcinoma, Squamous Cell; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Melanoma; Carcinoma, Hepatocellular
Details
Encapsulated pancreatic cancer vaccine(Therapyx)PCX-12Phase 1 ClinicalTherapyX IncPancreatic Neoplasms
Details

Inverkehr gebrachte Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaFrühestes MarkennameFrühestes GenehmigungslandFrüheste IndikationFrüheste GenehmigungsgesellschaftFrüheste GenehmigungsdatumIndikationenKlinische Studie
Ustekinumab biosimilar (Samsung Bioepis)SB-17; SB17ApprovedSamsung Bioepis Co LtdPyzchivaEUCrohn Disease; Colitis, UlcerativeSamsung Bioepis Nl Bv2024-04-19Gastrointestinal Diseases; Skin Diseases; Psoriasis; Arthritis, Psoriatic; Rheumatic Diseases; Colitis, Ulcerative; Inflammation; Crohn Disease; Plaque psoriasis
Details
  • Produktanfrage
  • Inverkehr gebrachte Arzneimittelinformation
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns